sepsis News
Most Popular sepsis Story
ALSO NOTED: CRO market hits $14B; Merck ends BioXell pact; and much more...
> Merck has ended its collaboration with BioXell on its sepsis drug TREM-1. BioXell says it will seek another company with which to partner on the drug. Report > Shire... Read more...
Latest Headlines
- January 10, 2007
- November 2, 2006
- October 18, 2006
- September 5, 2006
- December 7, 2005
- August 28, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
